Evidence map›Paper›PMID 24896764›Full record

ArticleThe American journal of gastroenterology2014

PACSIN2 does not influence thiopurine-related toxicity in patients with inflammatory bowel disease.

Rebecca L Roberts, Mary C Wallace, Margien L Seinen, Krupa Krishnaprasad, Angela Chew, Ian Lawrance, Ruth Prosser, Peter Bampton, Rachel Grafton, Lisa Simms and 5 more

Erratum issuedAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in The American journal of gastroenterology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. PACSIN proteins in vivo: Roles in development and physiology.Acta physiologica (Oxford, England) · 2022
    Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Rebecca L Roberts1] Department of Surgical Sciences (Dunedin), VU University Medical Center, Amsterdam, The Netherlands [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
Mary C Wallace1] Department of Surgical Sciences (Dunedin), VU University Medical Center, Amsterdam, The Netherlands [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
Margien L SeinenDepartment of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands.
Krupa Krishnaprasad1] QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital, Brisbane, Queensland, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
Angela Chew1] Centre for Inflammatory Bowel Disease, Fremantle Hospital, Fremantle, Western Australia, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
Ian Lawrance1] Centre for Inflammatory Bowel Disease, Fremantle Hospital, Fremantle, Western Australia, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
Ruth Prosser1] Flinders Medical Centre, Flinders University of South Australia, Bedford Park, South Australia, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
Peter Bampton1] Flinders Medical Centre, Flinders University of South Australia, Bedford Park, South Australia, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
Rachel Grafton1] Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, South Australia, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
Lisa Simms1] QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital, Brisbane, Queensland, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
Corrie Studd
Sally J Bell
Graham Radford-Smith1] QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital, Brisbane, Queensland, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
Jane M Andrews1] Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, South Australia, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
Murray L Barclay1] Department of Gastroenterology, Christchurch Hospital, Christchurch, New Zealand [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
Amsterdam UMC Location Vrije Universiteit Amsterdam · NLQIMR Berghofer Medical Research Institute · AUFlinders University · AUFremantle Hospital · AURoyal Adelaide Hospital · AUChristchurch Hospital · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug-Related Side Effects and Adverse ReactionsGastrointestinal TractAdaptor Proteins, Signal TransducingFemaleHumansMaleMercaptopurineMethyltransferasesAdaptor Proteins, Signal TransducingMercaptopurineMethyltransferases

Identifiers

PMID24896764
OpenAlexW2092909562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.